Tailoring platelet inhibition according to multiple electrode aggregometry decreases the rate of thrombotic complications after intracranial flow-diverting stent implantation

ORAN İ., ÇINAR C., BOZKAYA H., KORKMAZ M.

JOURNAL OF NEUROINTERVENTIONAL SURGERY, vol.7, no.5, pp.357-362, 2015 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 5
  • Publication Date: 2015
  • Doi Number: 10.1136/neurintsurg-2013-011023
  • Title of Journal : JOURNAL OF NEUROINTERVENTIONAL SURGERY
  • Page Numbers: pp.357-362

Abstract

Background and purpose Pretreatment with dual antiaggregant drugs is accepted as a standard step in intracranial stent implantation. The aim of this study was to determine whether tailored antiaggregant medication based on platelet reactivity testing with multiple electrode aggregometry (Multiplate) yields superior outcomes after intracranial flow-diverting stent (FDS) implantation compared with standard clopidogrel treatment.